Regulation of specific target genes and biological responses by estrogen receptor subtype agonists

Current Opinion in Pharmacology

Volumn 10, Issue 6, 2010, Pages 629-636

  Leitman, Dale C ^a   Paruthiyil, Sreenivasan ^b   Vivar, Omar I ^a   Saunier, Elise F ^b   Herber, Candice B ^a   Cohen, Isaac ^b   Tagliaferri, Mary ^b   Speed, Terence P ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Bionovo Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHALCONE; ESTROGEN RECEPTOR AGONIST; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA SELECTIVE AGONIST; FACTOR AF2; GLYCYRRHIZA EXTRACT; MF 101; NICOTINAMIDE ADENINE DINUCLEOTIDE; NYSASOL; PLACEBO; PRINABEREL; PUERARIA EXTRACT; SELECTIVE ESTROGEN RECEPTOR MODULATOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; BINDING AFFINITY; BINDING SITE; BREAST CANCER; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DOWN REGULATION; DRUG ACTIVITY; DRUG DESIGN; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; GENE TARGETING; HEART INFARCTION; HEART PROTECTION; HORMONE BINDING; HOT FLUSH; HUMAN; INFLAMMATORY DISEASE; INSULIN RESISTANCE; LIGAND BINDING; NIGHT SWEAT; NONHUMAN; OBESITY; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; REGULATORY SEQUENCE; REVIEW; UPREGULATION; VAGINAL DRYNESS; VAGINITIS; WEIGHT GAIN;

BREAST NEOPLASMS; CELL LINE; CHROMATIN ASSEMBLY AND DISASSEMBLY; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; GENE EXPRESSION; GENE REGULATORY NETWORKS; HOT FLASHES; HUMANS; INFLAMMATION; LIGANDS; MENOPAUSE; MOLECULAR TARGETED THERAPY; NUCLEAR RECEPTOR COACTIVATORS; PROTEIN BINDING; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TRANSCRIPTION FACTORS; WEIGHT GAIN;

EID: 78149495213     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2010.09.009     Document Type: Review

References (46)

1. Writing Group for the Women's Health Initiative: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333.
2. Shang Y. Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis. Nat Rev Cancer 2006, 6:360-368.
3. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., Tujague M., Strom A., Treuter E., Warner M., et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev 2007, 87:905-931.
4. Levin E.R. Plasma membrane estrogen receptors. Trends Endocrinol Metab 2009, 20:477-482.
5. Stauffer S.R., Coletta C.J., Tedesco R., Nishiguchi G., Carlson K., Sun J., Katzenellenbogen B.S., Katzenellenbogen J.A. Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J Med Chem 2000, 43:4934-4947.
6. Harris H.A., Albert L.M., Leathurby Y., Malamas M.S., Mewshaw R.E., Miller C.P., Kharode Y.P., Marzolf J., Komm B.S., Winneker R.C., et al. Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology 2003, 144:4241-4249.
7. Meyers M.J., Sun J., Carlson K.E., Marriner G.A., Katzenellenbogen B.S., Katzenellenbogen J.A. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 2001, 44:4230-4251.
8. Cvoro A., Paruthiyil S., Jones J.O., Tzagarakis-Foster C., Clegg N.J., Tatomer D., Medina R.T., Tagliaferri M., Schaufele F., Scanlan T.S., et al. Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract. Endocrinology 2007, 148:538-547.
9. Mersereau J.E., Levy N., Staub R.E., Baggett S., Zogric T., Chow S., Ricke W.A., Tagliaferri M., Cohen I., Bjeldanes L.F., et al. Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist. Mol Cell Endocrinol 2008, 283:49-57.
10. Minutolo F., Macchia M., Katzenellenbogen B.S., Katzenellenbogen J.A. Estrogen receptor beta ligands: recent advances and biomedical applications. Med Res Rev 2009, doi:10.1002/med.20186.
11. Monroe D.G., Getz B.J., Johnsen S.A., Riggs B.L., Khosla S., Spelsberg T.C. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta. J Cell Biochem 2003, 90:315-326.
12. Kian Tee M., Rogatsky I., Tzagarakis-Foster C., Cvoro A., An J., Christy R.J., Yamamoto K.R., Leitman D.C. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors {alpha} and {beta}. Mol Biol Cell 2004, 15:1262-1272.
13. Paruthiyil S., Cvoro A., Zhao X., Wu Z., Sui Y., Staub R.E., Baggett S., Herber C.B., Griffin C., Tagliaferri M., et al. Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists. PLoS ONE 2009, 4:e6271.
14. Stossi F., Barnett D.H., Frasor J., Komm B., Lyttle C.R., Katzenellenbogen B.S. Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) alpha or ERbeta in human osteosarcoma cells: distinct and common target genes for these receptors. Endocrinology 2004, 145:3473-3486.
15. Vivar O.I., Zhao X., Saunier E.F., Griffin C., Mayba O.S., Tagliaferri M., Cohen I., Speed T.P., Leitman D.C. Estrogen receptor [beta] binds to and regulates three distinct classes of target genes. J Biol Chem 2010, 285:22059-22066.
16. Levy N., Paruthiyil S., Zhao X., Vivar O.I., Saunier E.F., Griffin C., Tagliaferri M., Cohen I., Speed T.P., Leitman DC Unliganded estrogen receptor-beta regulation of genes is inhibited by tamoxifen. Mol Cell Endocrinol 2010, 315:201-207.
17. Charn T.H., Liu E.T., Chang E.C., Lee Y.K., Katzenellenbogen J.A., Katzenellenbogen B.S. Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection. Mol Endocrinol 2010, 24:47-59.
18. Liu Y., Gao H., Marstrand T.T., Strom A., Valen E., Sandelin A., Gustafsson J.A., Dahlman-Wright K. The genome landscape of ERalpha- and ERbeta-binding DNA regions. Proc Natl Acad Sci USA 2008, 105:2604-2609.
19. Carroll J.S., Liu X.S., Brodsky A.S., Li W., Meyer C.A., Szary A.J., Eeckhoute J., Shao W., Hestermann E.V., Geistlinger T.R., et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122:33-43.
20. Carroll J.S., Meyer C.A., Song J., Li W., Geistlinger T.R., Eeckhoute J., Brodsky A.S., Keeton E.K., Fertuck K.C., Hall G.F., et al. Genome-wide analysis of estrogen receptor binding sites. Nat Genet 2006, 38:1289-1297.
21. Lupien M., Eeckhoute J., Meyer C.A., Wang Q., Zhang Y., Li W., Carroll J.S., Liu X.S., Brown M. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 2008, 132:958-970.
22. Welboren W.J., van Driel M.A., Janssen-Megens E.M., van Heeringen S.J., Sweep F.C., Span P.N., Stunnenberg H.G. ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J 2009, 28:1418-1428.
23. Lin C.Y., Vega V.B., Thomsen J.S., Zhang T., Kong S.L., Xie M., Chiu K.P., Lipovich L., Barnett D.H., Stossi F., et al. Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet 2007, 3:e87.
24. Levy N., Zhao X., Tang H., Jaffe R.B., Speed T.P., Leitman D.C. Multiple transcription factor elements collaborate with estrogen receptor {alpha} to activate an inducible estrogen response element in the NKG2E gene. Endocrinology 2007, 148:3449-3458.
25. Metivier R., Penot G., Hubner M.R., Reid G., Brand H., Kos M., Gannon F. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003, 115:751-763.
26. Stanisic V., Lonard D.M., O'Malley B.W. Modulation of steroid hormone receptor activity. Prog Brain Res 2010, 181:153-176.
27. Kouzu-Fujita M., Mezaki Y., Sawatsubashi S., Matsumoto T., Yamaoka I., Yano T., Taketani Y., Kitagawa H., Kato S. Coactivation of estrogen receptor beta by gonadotropin-induced cofactor GIOT-4. Mol Cell Biol 2009, 29:83-92.
28. Garcia-Pedrero J.M., Kiskinis E., Parker M.G., Belandia B. The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells. J Biol Chem 2006, 281:22656-22664.
29. Malamas M.S., Manas E.S., McDevitt R.E., Gunawan I., Xu Z.B., Collini M.D., Miller C.P., Dinh T., Henderson R.A., Keith J.C., et al. Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands. J Med Chem 2004, 47:5021-5040.
30. Manas E.S., Unwalla R.J., Xu Z.B., Malamas M.S., Miller C.P., Harris H.A., Hsiao C., Akopian T., Hum W.T., Malakian K., et al. Structure-based design of estrogen receptor-beta selective ligands. J Am Chem Soc 2004, 126:15106-15119.
31. Bowe J., Li X.F., Kinsey-Jones J., Heyerick A., Brain S., Milligan S., O'Byrne K. The hop phytoestrogen, 8-prenylnaringenin, reverses the ovariectomy-induced rise in skin temperature in an animal model of menopausal hot flushes. J Endocrinol 2006, 191:399-405.
32. Grady D., Sawaya G.F., Johnson K.C., Koltun W., Hess R., Vittinghoff E., Kristof M., Tagliaferri M., Cohen I., Ensrud K.E. MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial. Menopause 2009, 16:458-465.
33. Strom A., Hartman J., Foster J.S., Kietz S., Wimalasena J., Gustafsson J.A. Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 2004, 101:1566-1571.
34. Paruthiyil S., Parmar H., Kerekatte V., Cunha G.R., Firestone G.L., Leitman D.C. Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 2004, 64:423-428.
35. Hall J.M., McDonnell D.P. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999, 140:5566-5578.
36. Monroe D.G., Secreto F.J., Subramaniam M., Getz B.J., Khosla S., Spelsberg T.C. Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells. Mol Endocrinol 2005, 19:1555-1568.
37. Cristofaro P.A., Opal S.M., Palardy J.E., Parejo N.A., Jhung J., Keith J.C., Harris H.A. WAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shock. Crit Care Med 2006, 34:2188-2193.
38. Harris H.A., Bruner-Tran K.L., Zhang X., Osteen K.G., Richard Lyttle C. A selective estrogen receptor-{beta} agonist causes lesion regression in an experimentally induced model of endometriosis. Hum Reprod 2005, 20:936-941.
39. Cvoro A., Tatomer D., Tee M.K., Zogovic T., Harris H.A., Leitman D.C. Selective estrogen receptor-agonists repress transcription of proinflammatory genes. J Immunol 2008, 180:630-636.
40. Lin J., Steenbergen C., Murphy E., Sun J. Estrogen receptor-beta activation results in S-nitrosylation of proteins involved in cardioprotection. Circulation 2009, 120:245-254.
41. Grumbach M.M., Auchus R.J. Estrogen: consequences and implications of human mutations in synthesis and action. J Clin Endocrinol Metab 1999, 84:4677-4694.
42. Harris H.A., Katzenellenbogen J.A., Katzenellenbogen B.S. Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand. Endocrinology 2002, 143:4172-4177.
43. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 2000, 97:12729-12734.
44. Lundholm L., Bryzgalova G., Gao H., Portwood N., Falt S., Berndt K.D., Dicker A., Galuska D., Zierath J.R., Gustafsson J.A., et al. The estrogen receptor {alpha}-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice; potential molecular mechanisms. J Endocrinol 2008, 199:275-286.
45. Helguero L.A., Faulds M.H., Gustafsson J.A., Haldosen L.A. Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 2005, 24:6605-6616.
46. Krum S.A., Miranda-Carboni G.A., Lupien M., Eeckhoute J., Carroll J.S., Brown M. Unique ERalpha cistromes control cell type-specific gene regulation. Mol Endocrinol 2008, 22:2393-2406.